Butylphthalide for long-term recovery after a mild stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether a medication called butylphthalide helps with long-term recovery after a mild stroke. It might improve thinking and memory over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 40 and 80 years old.
- You had a recent mild stroke (within the last 2 weeks) confirmed by an MRI scan.
- You had little or no disability before the stroke.
- You have no history of dementia or severe memory problems.
- Your stroke is not caused by a heart condition (like atrial fibrillation) or other specific causes such as bleeding or major blockage in the neck artery.
- You are not currently taking certain memory-enhancing medications or have not taken them in the past 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication (bevifibatide) to see which dose works best for people having an ischemic stroke who cannot get standard treatments like clot-busting drugs or a procedure to remove the clot. It aims to improve recovery by stopping clots from getting worse.
This Phase 3 study tests whether butyphthalide can help thinking and memory improve after an acute ischemic stroke. It compares people who take the study medicine versus usual care, and measures cognitive (thinking) changes over follow-up.
This trial tests whether butylphthalide, given after a procedure to remove a blood clot from the brain, can help reduce dangerous brain swelling. If you've had a severe stroke and recently had a clot-removal procedure, this drug might improve your recovery.
This trial tests whether adding butylphthalide (a drug that improves blood flow) to the standard clot-busting medicine tenecteplase can help people with mild but disabling strokes recover better. If you have had a mild stroke within the last 4.5 hours and are 18–80, this study might be an option for you.
This study tests whether a medicine called butylphthalide can help improve memory and thinking in older adults with focal epilepsy who already have mild cognitive issues. It aims to find a new way to support brain health in people with epilepsy.
This study tests two medications, isosorbide mononitrate and butylphthalide, to see if taking them early after a small type of stroke (called lacunar) can reduce the chances of long-term disability. You would receive one of these medications or a placebo, and the study will follow your recovery over time.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.